NewsBenzingaNovartis: utile per azione rettificato del terzo trimestre a 2,46 dollari, batte le stime di 2,27 dollari; ricavi a 14,522 miliardi di dollari, sotto le stime di 14,582 miliardi di dollari Novartis: utile per azione rettificato del terzo trimestre a 2,46 dollari, batte le stime di 2,27 dollari; ricavi a 14,522 miliardi di dollari, sotto le stime di 14,582 miliardi di dollari Benzinga 2026.10.27 07:01 (GMT+0) Open on Benzinga Other news Nvidia Plans $3 Billion Investment for Stake in Meta, Deepening Collaboration on AI Assistant Muse Gate Ventures: U.S. Stocks and Crypto Markets Both Diverge, Primary-Market Fundraising Rebounds Sharply With Infrastructure in Absolute Dominance Blackstone: Q3 Shows The Private Credit Scare Was Overdone, And The Stock Is Still Cheap Binance to Remove Multiple Spot Trading Pairs Including AAVE/BTC and ATOM/BTC on October 30 Meme Coin and AI Agent Launchpad Bullshot Raises $7.7M, Led by Animoca Brands and Others Top Wall Street Forecasters Revamp PayPal Expectations Ahead Of Q3 Earnings
Gate Ventures: U.S. Stocks and Crypto Markets Both Diverge, Primary-Market Fundraising Rebounds Sharply With Infrastructure in Absolute Dominance
